Provided by Tiger Trade Technology Pte. Ltd.

Viatris Inc.

16.33
-0.0150-0.09%
Volume:1.36M
Turnover:22.07M
Market Cap:18.76B
PE:-46.07
High:16.37
Open:16.29
Low:16.12
Close:16.34
52wk High:18.39
52wk Low:9.43
Shares:1.15B
Float Shares:1.14B
Volume Ratio:0.49
T/O Rate:0.12%
Dividend:0.48
Dividend Rate:2.94%
EPS(TTM):-0.3543
EPS(LYR):-3.0024
ROE:-2.75%
ROA:2.67%
PB:1.32
PE(LYR):-5.44

Loading ...

Viatris Inc: Files for Euro Denominated Notes Offering, Size Not Disclosed - SEC Filing

THOMSON REUTERS
·
Jun 12

Viatris Inc. Stock Rises Thursday, Outperforms Market

Dow Jones
·
Jun 12

Australia's Therapeutic Goods Administration: Viatris Notified US Supply Constraints Affecting Creon 25,000 Unit and Creon 35,000 Unit Capsules Will Continue Until Jan 31, 2027

THOMSON REUTERS
·
Jun 11

Australia's Tga: Supply Constraints Affecting Creon Units Due to an Unexpected Global Increase in Demand

THOMSON REUTERS
·
Jun 11

Australia's Tga: Viatris Will Continue to Receive Regular Supplies of All Strengths of Creon in Australia; Availability May Be Limited

THOMSON REUTERS
·
Jun 11

Viatris Inc. Stock Rises Tuesday, Outperforms Market

Dow Jones
·
Jun 10

Noveris Health Sciences appoints Geoff Griffiths as strategic advisor

Reuters
·
Jun 09

Viatris Inc. Stock Rises Thursday, Outperforms Market

Dow Jones
·
Jun 05

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Viatris (VTRS), Medtronic (MDT) and Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Jun 04

Salesforce says Viatris selects Agentforce Life Sciences as global customer engagement platform

Reuters
·
Jun 02

Viatris Inc. Stock Falls Monday, Underperforms Market

Dow Jones
·
Jun 02

Viatris Inc. Stock Falls Thursday, Underperforms Market

Dow Jones
·
May 29

Argus Raises Viatris Price Target to $18 From $15

MT Newswires Live
·
May 28

Viatris Inc. Stock Falls Tuesday, Underperforms Market

Dow Jones
·
May 27

Viatris Inc. Stock Rises Friday, Outperforms Market

Dow Jones
·
May 23

Viatris Inc. Stock Rises Wednesday, Outperforms Market

Dow Jones
·
May 21

Viatris Inc. Stock Falls Tuesday, Underperforms Market

Dow Jones
·
May 20

Viatris Is Maintained at Overweight by Barclays

Dow Jones
·
May 19

Barclays Adjusts Price Target on Viatris to $22 From $17, Maintains Overweight Rating

MT Newswires Live
·
May 19

Viatris price target raised to $22 from $17 at Barclays

TIPRANKS
·
May 19